Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ka, Taskén"'
Autor:
Taskén K, Bs, Skålhegg, Ka, Taskén, Solberg R, Hk, Knutsen, Fo, Levy, Mårten Sandberg, Orstavik S, Larsen T, Ak, Johansen, Vang T, Hp, Schrader, Nt, Reinton, Km, Torgersen, Hansson V, Jahnsen T
Publikováno v:
Europe PubMed Central
A large number of hormones, neurotransmitters, and other signaling substances that bind to G-protein-coupled cell-surface receptors have their signals converge at one sole second messenger, cAMP. The question of how specificity can be maintained in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b2de1b7f9f181d8e5d0a733ffe2ce63d
http://europepmc.org/abstract/med/9344252
http://europepmc.org/abstract/med/9344252
Autor:
Guldvik IJ; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. inguld@ous-hf.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. inguld@ous-hf.no., Ramberg H; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Kristensen G; Department of Urology, Center for Cancer and Organ Diseases, Copenhagen Prostate Cancer Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Røder A; Department of Urology, Center for Cancer and Organ Diseases, Copenhagen Prostate Cancer Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Mills IG; Cancer Research UK, Li Ka Shing Centre, Cambridge Research Institute, Cambridge, UK.; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Patrick G. Johnston Centre for Cancer Research, Queen's University of Belfast, Belfast, UK., Lilleby W; Department of Oncology, Oslo University Hospital, Oslo, Norway., Taskén KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
World journal of urology [World J Urol] 2024 Feb 22; Vol. 42 (1), pp. 95. Date of Electronic Publication: 2024 Feb 22.
Autor:
Nunes-Xavier CE; Biomarkers in Cancer Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. Electronic address: carolinenunesxavier@gmail.com., Emaldi M; Biomarkers in Cancer Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. Electronic address: maite.emaldimartinezdeilarduya@osakidetza.eus., Guldvik IJ; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. Electronic address: ingrid.jenny.guldvik@rr-research.no., Ramberg H; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. Electronic address: hakon.ramberg@rr-research.no., Taskén KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway. Electronic address: k.a.tasken@medisin.uio.no., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; University of Tromsø - The Arctic University of Norway, Tromsø, Norway. Electronic address: g.m.malandsmo@ous-research.no., Fodstad Ø; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. Electronic address: fodstadoystein@gmail.com., Llarena R; Department of Urology, Cruces University Hospital, Barakaldo, Spain. Electronic address: roberto.llarenaibarguren@osakidetza.eus., Pulido R; Biomarkers in Cancer Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain. Electronic address: rpulidomurillo@gmail.com., López JI; Biomarkers in Cancer Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. Electronic address: jilpath@gmail.com.
Publikováno v:
Pathology, research and practice [Pathol Res Pract] 2023 Jan; Vol. 241, pp. 154243. Date of Electronic Publication: 2022 Nov 24.
Autor:
Guldvik IJ; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Braadland PR; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Norwegian PSC Research Center, Department of Transplantation Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Sivanesan S; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Urology, Oslo University Hospital, Oslo, Norway., Ramberg H; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Kristensen G; Copenhagen Prostate Cancer Center, Department of Urology, Center for Cancer and Organ diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Tennstedt P; Martini-Klinik Prostate Cancer Centre, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Røder A; Copenhagen Prostate Cancer Center, Department of Urology, Center for Cancer and Organ diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Schlomm T; Martini-Klinik Prostate Cancer Centre, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany., Berge V; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Urology, Oslo University Hospital, Oslo, Norway., Eri LM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Urology, Oslo University Hospital, Oslo, Norway., Lilleby W; Department of Oncology, Oslo University Hospital, Oslo, Norway., Mills IG; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.; Patrick G. Johnston Centre for Cancer Research, Queen's University of Belfast, Belfast, UK., Taskén KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2022 Oct 04; Vol. 45, pp. 68-75. Date of Electronic Publication: 2022 Oct 04 (Print Publication: 2022).
Autor:
Sivanesan S; Department of Urology, Oslo University Hospital, Oslo, Norway.; Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Taskén KA; Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Grytli HH; Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Jan 04; Vol. 5 (1), pp. e2145230. Date of Electronic Publication: 2022 Jan 04.
Autor:
Guerriero I; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Biogem, Istituto di Biologia e Genetica Molecolare, Ariano Irpino, Avellino, Italy., Ramberg H; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Sagini K; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Ramirez-Garrastacho M; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Taskén KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Llorente A; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Mechanical, Electronics and Chemical Engineering, Faculty of Technology, Art and Design, Oslo Metropolitan University, Oslo, Norway.
Publikováno v:
PloS one [PLoS One] 2021 Jun 30; Vol. 16 (6), pp. e0253828. Date of Electronic Publication: 2021 Jun 30 (Print Publication: 2021).
Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer.
Autor:
Ramberg H; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Richardsen E; Department of Medical Biology, The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., de Souza GA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.; Department of Immunology, Proteomics Core Facility, Oslo University Hospital, Oslo, Norway., Rakaee M; Department of Medical Biology, The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway., Stensland ME; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.; Department of Immunology, Proteomics Core Facility, Oslo University Hospital, Oslo, Norway., Braadland PR; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Nygård S; Department of Tumorbiology, Bioinformatic Core Facility, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Ögren O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Guldvik IJ; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Berge V; Department of Urology, Oslo University Hospital, Oslo, Norway., Svindland A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Taskén KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Andersen S; Department of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
Publikováno v:
Carcinogenesis [Carcinogenesis] 2021 May 28; Vol. 42 (5), pp. 685-693.
Autor:
Guldvik IJ; Prostate Cancer Research Group, Centre for Molecular Medicine Norway, University of Oslo and Oslo University Hospital, Oslo, Norway.; Department of Tumour Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Zuber V; MRC Biostatistics Unit, Cambridge University, Cambridgeshire, UK.; Department of Epidemiology and Biostatistics, Imperial College London, London, UK., Braadland PR; Department of Tumour Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Grytli HH; Department of Tumour Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Ramberg H; Department of Tumour Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Lilleby W; Department of Oncology, Oslo University Hospital, Oslo, Norway., Thiede B; Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway.; Department of Biosciences, University of Oslo, Oslo, Norway., Zucknick M; Department of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Oslo, Norway., Saatcioglu F; Department of Biosciences, University of Oslo, Oslo, Norway., Gislefoss R; Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway., Kvåle R; Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Health Registry Research and Development, Norwegian Institute of Public Health, Bergen, Norway., George A; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials, Cambridge, UK., Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden., Wiklund F; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden., Neal DE; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials, Cambridge, UK., Taskén KA; Department of Tumour Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Mills IG; Prostate Cancer Research Group, Centre for Molecular Medicine Norway, University of Oslo and Oslo University Hospital, Oslo, Norway.; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.; Department of Molecular Oncology, Oslo University Hospitals, Oslo, Norway.; Department of Urology, Oslo University Hospitals, Oslo, Norway.; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2020 Oct 13; Vol. 21, pp. 51-60. Date of Electronic Publication: 2020 Oct 13 (Print Publication: 2020).
Autor:
Nome ME; Department of Clinical Molecular Biology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Euceda LR; Department of Circulation and Medical Imaging, NTNU - The Norwegian University of Science and Technology, Trondheim, Norway., Jabeen S; Department of Clinical Molecular Biology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Debik J; Department of Circulation and Medical Imaging, NTNU - The Norwegian University of Science and Technology, Trondheim, Norway., Bathen TF; Department of Circulation and Medical Imaging, NTNU - The Norwegian University of Science and Technology, Trondheim, Norway., Giskeødegård GF; Department of Circulation and Medical Imaging, NTNU - The Norwegian University of Science and Technology, Trondheim, Norway., Taskén KA; Department of Tumour Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Maelandsmo GM; Department of Tumour Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway.; Institute of Medical Biology, Faculty of Health Sciences, Artic University of Norway - University of Tromsø, Tromsø, Norway., Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Yndestad A; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Borgen E; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Garred Ø; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.; K.G. Jebsen - Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Tromsø - The Arctic University of Norway, Tromsø, Norway., Ueland T; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen - Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Tromsø - The Arctic University of Norway, Tromsø, Norway., Engebraaten O; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kristensen VN; Department of Clinical Molecular Biology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Tekpli X; Department of Clinical Molecular Biology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Publikováno v:
International journal of cancer [Int J Cancer] 2020 Jan 01; Vol. 146 (1), pp. 223-235. Date of Electronic Publication: 2019 Oct 08.
Autor:
Braadland PR; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ramberg H; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Grytli HH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Urbanucci A; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway.; Department of Core Facilities, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway., Nielsen HK; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Guldvik IJ; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Engedal A; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Ketola K; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland., Wang W; Clinical Pathology/Cytology, Karolinska University Hospital, Stockholm, Sweden., Svindland A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Mills IG; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway.; Movember FASTMAN Centre of Excellence, Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, United Kingdom.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom., Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden.; Department of Translational Medicine, Division of Urological Cancers, Lund University, Malmø, Sweden., Taskén KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. k.a.tasken@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2019 Nov; Vol. 17 (11), pp. 2154-2168. Date of Electronic Publication: 2019 Aug 08.